首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   16142篇
  免费   1104篇
  国内免费   78篇
耳鼻咽喉   144篇
儿科学   338篇
妇产科学   334篇
基础医学   1980篇
口腔科学   353篇
临床医学   1605篇
内科学   3171篇
皮肤病学   196篇
神经病学   1582篇
特种医学   637篇
外科学   2508篇
综合类   189篇
现状与发展   1篇
一般理论   29篇
预防医学   1370篇
眼科学   520篇
药学   1256篇
中国医学   29篇
肿瘤学   1082篇
  2024年   18篇
  2023年   147篇
  2022年   292篇
  2021年   630篇
  2020年   308篇
  2019年   466篇
  2018年   549篇
  2017年   403篇
  2016年   413篇
  2015年   508篇
  2014年   684篇
  2013年   820篇
  2012年   1330篇
  2011年   1290篇
  2010年   701篇
  2009年   663篇
  2008年   1026篇
  2007年   1041篇
  2006年   978篇
  2005年   995篇
  2004年   853篇
  2003年   775篇
  2002年   706篇
  2001年   154篇
  2000年   109篇
  1999年   127篇
  1998年   138篇
  1997年   108篇
  1996年   93篇
  1995年   82篇
  1994年   64篇
  1993年   54篇
  1992年   64篇
  1991年   52篇
  1990年   50篇
  1989年   57篇
  1988年   41篇
  1987年   36篇
  1986年   27篇
  1985年   24篇
  1984年   34篇
  1983年   30篇
  1982年   33篇
  1981年   39篇
  1980年   32篇
  1979年   18篇
  1978年   19篇
  1977年   15篇
  1976年   17篇
  1975年   16篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
62.
An important operational aspect of Syringe Exchange Programmes (SEPs) is the venue of service delivery. This report describes the programmatic features of the Sacramento Area Needle Exchange (SANE), an illegal SEP operating in California, USA. SANE utilises “satellite exchangers” to distribute the bulk of its syringes and HIV risk reduction supplies. Advantages of relying primarily on Designated Exchangers (DE) for delivery of SEP services are that it: (1) allows for coverage of a large geographical area; (2) keeps operational cost low; (3) provides syringes to clients who may not want to or cannot use fixed site programmes; (4) limits the possibility of detection of programme personnel and clients by law enforcement. Limitations are that: (1) it is not as conducive as fixed sites to providing a wide range of ancillary services; (2) it may not be optimal for drug users who do not want to be reliant on other people for access to syringes; (3) those who receive services from a satellite exchanger may not derive as much counselling and referral services as direct exchangers. The lack of legal status, political support and adequate funding threatens the programme’s existence.  相似文献   
63.
64.
65.
Abstract: The main aim of the present investigation was to study systematically the passive and stimulation-evoked release of 3H-5-hydroxytryptamine (3H-5-HT) from rabbit isolated aorta. This was accomplished by preloading rings of aorta with 3H-5-HT (10–6M) and then monitoring by fractional collection the basal 3H-outflow and stimulation-evoked 3H-overflow. The basal 3H-outflow from aorta preloaded with 10–6M of either 3H-5-HT or (-)-3H-noradrenaline (3H-NA) leveled off about 100 min. after the onset of wash-out and remained almost constant thereafter (100–240 min.). The basal 3H-outflow from tissue preloaded with 3H-5-HT was almost 3-fold higher (70–240 min.) than that seen after preloading with 3H-NA. Cocaine (3x10–5M) did not alter the basal 3H-outflow (15–240 min.) from tissue preloaded with 3H-5-HT, while pargyline (5X10–4M) decreased it by about 66% (100–240 min.). Electrical-field stimulation (S1S7, 200 mA, 600 pulses, 0.5 msec, 3 Hz) were applied to the tissue. The initial stimulation-evoked 3H-overflow from aorta preloaded with 3H-5-HT was higher than the subsequent ones (S1-S7: 100, 35, 35, 35, 35, 37, and 40%). Similar results to these were obtained with tissues preloaded with 3H-NA. The stimulation (S1-S7; 200 mA; 600 pulses, 0.5 msec, 3 Hz)-evoked 3H-overflow increased in an apparent linear manner with the amount of current used (50–200 mA). This was also the case for number of pulses (100–900) in the stimulus. The stimulation-evoked 3H-overflow depended in part on the stimulation frequency: unchanged at 2–4 Hz; small increase at 8 Hz; and a 15-fold increase at 16 Hz relative to 2 Hz. Tetrodotoxin (10–6M) decreased the stimulation-evoked 3H-overflow from aorta preloaded with 3H-5-HT (S2-S6) by about 60%, while S1 was not affected. The inhibitory effect of tetrodotoxin was fully reversed by washing the aorta with drug-free salt solution. Omission of Ca2+ from the salt solution reduced the stimulation 3H-overflow by 47–57% (S2-S6) while S1 was unaffected. 6-Hydroxydopamine markedly increased the stimulation-evoked 3H-overflow from 3H-5-HT preloaded rings (180–323% of control). Pargyline (5x10–4M), cocaine (3x10–5M) and removal of endothelium did not alter the stimulation-evoked 3H-overflow evoked by stimulation (S1-S6) of aorta preloaded with 3H-5-HT. It is concluded that 3H-5-HT can be released by electrical-field stimulation as a “false transmitter'’from rabbit isolated aorta. Most of the release is probably of neuronal origin. However, some of the stimulation-evoked 3H-overflow is derived from extraneuronal sites.  相似文献   
66.
67.
68.
Abstract: The vitamin D analogue MC 1288 (20-epi-1α,25-dihydroxycholecalciferol) effectively postpones rejection of cardiac, intestinal, skin, and aortic allografts. MC 1288 binds to the vitamin D receptor and is thus assumed to exert its immunosuppressive effects via the same mechanisms as 1α,25-dihydroxycholecalciferol, the active form of vitamin D. 1α,25-Dihydroxycholecalciferol has been demonstrated to inhibit the production of various cytokines (interleukin-2, interferon-γ, granulocyte macrophage colony-stimulating factor, and interleukin-12) and to prevent B lymphocyte secretion of immunoglobulins. In the present study MC 1288 was evaluated for its ability to prevent rejection of mouse-to-rat cardiac xenografts, alone and in combination with 15-deoxyspergualin (DSG). Combined treatment with MC 1288 (given days -1 to 9) and DSG (given day -1 and onward) postponed rejection from day 3.0 (untreated recipients) until day 19.5. In rats treated with MC 1288 or DSG as monotherapy, rejection occurred after 3.0 and 7.5 days, respectively. Functioning grafts, obtained on day 9 from recipients treated with MC 1288 and DSG in combination, displayed an almost normal morphology without any obvious deposition of immunoglobulins in the vessels of the grafts and with just a few infiltrating cells. Thus, we have demonstrated synergistic actions of MC 1288 and DSG in delaying rejection of xenografts. Analysis of cellular infiltration, immunoglobulin deposition and graft survival times in the various treatment groups indicate a combined inhibitory effect of these two drugs on the level of macrophage effector function, direct or indirect via T lymphocytes, as well as on antibody production.  相似文献   
69.
Two cases of staphylococcal lung disease in young infants are described. In each instance a life-threatening bronchopleural fistula in the acute phase was successfully managed by thoracotomy and suture repair. Offprint requests to: A. W. Auldist  相似文献   
70.
Background: It is not known whether epidural epinephrine has an analgesic effect per se. The segmental distribution of clonidine epidural analgesia and its effects on temporal summation and different types of noxious stimuli are unknown. The aim of this study was to clarify these issues.

Methods: Fifteen healthy volunteers received epidurally (L2-L3 or L3-L4) 20 ml of either epinephrine, 100 micro gram, in saline; clonidine, 8 micro gram/kg, in saline; or saline, 0.9%, alone, on three different days in a randomized, double-blind, cross-over fashion. Pain rating after electrical stimulation, pinprick, and cold perception were recorded on the dermatomes S1, L4, L1, T9, T6, T1, and forehead. Pressure pain tolerance threshold was recorded at S1, T6, and ear. Pain thresholds to single and repeated (temporal summation) electrical stimulation of the sural nerve were determined.

Results: Epinephrine significantly reduced sensitivity to pinprick at L1-L4-S1. Clonidine significantly decreased pain rating after electrical stimulation at L1-L4 and sensitivity to pinprick and cold at L1-L4-S1, increased pressure pain tolerance threshold at S1, and increased thresholds after single and repeated stimulation of the sural nerve.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号